Mercer Global Advisors
EWTX icon

Mercer Global Advisors’s Edgewise Therapeutics EWTX Stock Holding History

Mercer Global Advisors’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.6K Buy
+1,812
New +$62.5K ﹤0.01% 4065

Other funds holding EWTX

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JTL
Jupiter Topco LLC New York $245B AUM
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Mercer Global Advisors's EWTX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 1,812 shares worth $73.6K. The stake represents ﹤0.01% of the portfolio and ranks #4065 among its holdings.

205 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Mercer Global Advisors held 1,812 shares of Edgewise Therapeutics worth $73.6K as of Q2 2026.
  • Edgewise Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4065 holding.
  • 205 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.